drugset
drugset / Trial / NCT04501211

Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis

NCT04501211 ↗

Phase 2 Withdrawn Indiana University Kyowa Kirin, Inc. · collab
NaSingle-groupOpen-labelTreatment

Summary

To determine the efficacy of open -label transdermal patch on chronic nausea and emesis in patients with gastroparesis

Timeline

Start
2019-01-01
Primary completion
2020-12-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Granisetron Other / unclassified — Other

Indications

gastroparesis